During a first-quarter earnings conference call with investors, Allergan's chief executive, Brent Saunders, said that the company is “deep into the process” of its strategic review, which he outlined in a series of options. Allergan reported a revenue increase of 2.8 percent to $3.67 billion in the first quarter of ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.